Heidelberg Epignostix combines scientific, medical and technical expertise to improve diagnostic accuracy and clinical care for cancer patients.
The company conducts research and development, certification, and marketing of software solutions for molecular tumour classification using DNA methylation profiling and machine learning. Established in 2022, the company builds on decades of combined experience among its founders.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company conducts research and development, certification, and marketing of these solutions, which are based on DNA methylation profiling and machine learning.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 3, 2026, September 5, 2026, September 15, 2026, September 16, 2026, September 18, 2026, September 19, 2026, September 21, 2026, September 26, 2026, September 27, 2026, September 28, 2026 and September 30, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.